Comparison of Two Phase II Trials of Neoadjuvant Temozolomide Followed with Concomitant and Adjuvant Temozolomide and Hypofractionated Accelerated Radiotherapy with or without Metformin in Patients with Newly Diagnosed Glioblastoma

Autor: Shenouda, G., Petrecca, K., Abdulkarim, B.S., Owen, S., Panet-Raymond, V., Diaz, R., Guiot, M.C., Carvalho, T., Charbonneau, M., Hall, J., Souhami, L.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:S63-S63
Databáze: ScienceDirect